Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of fixed-dose vildagliptin + metformin 50/1000 mg vs Galvus Met 50/1000 mg under fed conditions in healthy Thai volunteers
TCTR20240817009Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vildagliptin + metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
vildagliptin + metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20240817009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240817009.